In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stryker Exercises New Innovation Muscles During COVID-19

Executive Summary

Many changes have come about for the orthopedic innovator Stryker as a result of the pandemic, says group CEO Kevin Lobo. The most important relates to methods of engagement with customers.

You may also be interested in...



Stryker Doubles Down On Novadaq To Boost Medsurg

Stryker is set to expand its surgical offerings after signing a $701m deal to buy Novadaq Technologies, a leading developer of fluorescence surgical imaging technology. The acquisition price is a 96% premium over Novadaq's June 16 closing price, which, according to analysts, is believed to be due to a competitive bidding process for the company.

Novel Models Of Care Must Feature In Updated UK NHS Plan

COVID has necessitated a refresh of NHS England’s Long Term Plan, which must double down on concepts such as at-home, patient-empowered care and virtual wards, says the NHS Confederation.

UK Medtech Strategy Promises To Use Innovation Effectively And Build Resilience

The UK MedTech Directorate has issued its much-awaited medical technology strategy for improving supply resilience and encouraging innovative and dynamic markets and sector diversity.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV124643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel